# Trastuzumab Optimization Trial in Breast Cancer

> **NCT00637325** · PHASE3 · UNKNOWN · sponsor: **Regione Lombardia** · enrollment: 500 (estimated)

## Conditions studied

- Metastatic or Locally Advanced Breast Cancer

## Interventions

- **DRUG:** trastuzumab

## Key facts

- **NCT ID:** NCT00637325
- **Lead sponsor:** Regione Lombardia
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-11
- **Primary completion:** 2009-05
- **Final completion:** 2011-04
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2008-03-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00637325

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00637325, "Trastuzumab Optimization Trial in Breast Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00637325. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*